Skip to main content
Erschienen in: Breast Cancer Research 5/2002

01.10.2002 | Review

Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis

verfasst von: Elizabeth Anderson

Erschienen in: Breast Cancer Research | Ausgabe 5/2002

Einloggen, um Zugang zu erhalten

Abstract

A relatively small number of cells in the normal human mammary gland express receptors for oestrogen and progesterone (ER and PR), and there is almost complete dissociation between steroid receptor expression and proliferation. Increased expression of the ER alpha (ERα) and loss of the inverse relationship between receptor expression and proliferation occur at the very earliest stages of tumorigenesis, implying that dysregulation of ERα expression contributes to breast tumour formation. There is evidence also for alterations in the ratio between the two PR isoforms in premalignant breast lesions. Elucidation of the factors mediating the effects of oestradiol and progesterone on development of the normal breast and of the mechanisms by which expression of the ERα and the PR isoforms is controlled could identify new targets for breast cancer prevention and improved prediction of breast cancer risk.
Literatur
1.
Zurück zum Zitat Russo J, Russo IH: Development of the human mammary gland. In The Mammary Gland. Development, Regulation and Function. Edited by: Neville M, Daniel CW. 1987, New York: Plenum;, 67-93.CrossRef Russo J, Russo IH: Development of the human mammary gland. In The Mammary Gland. Development, Regulation and Function. Edited by: Neville M, Daniel CW. 1987, New York: Plenum;, 67-93.CrossRef
2.
Zurück zum Zitat Anderson E, Clarke RB, Howell A: Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia. 1998, 3: 23-35. 10.1023/A:1018718117113.CrossRefPubMed Anderson E, Clarke RB, Howell A: Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia. 1998, 3: 23-35. 10.1023/A:1018718117113.CrossRefPubMed
3.
Zurück zum Zitat Allred DC, Mohsin SK, Fuqua SAW: Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer. 2001, 8: 47-61.CrossRefPubMed Allred DC, Mohsin SK, Fuqua SAW: Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer. 2001, 8: 47-61.CrossRefPubMed
4.
Zurück zum Zitat Laron Z, Pauli R, Pertzelan A: Clinical evidence on the role of estrogens in the development of the breasts. Proc R Soc Edinburgh B1. 1989, 95: 13-22. Laron Z, Pauli R, Pertzelan A: Clinical evidence on the role of estrogens in the development of the breasts. Proc R Soc Edinburgh B1. 1989, 95: 13-22.
5.
Zurück zum Zitat Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1984, 24: 29-43.CrossRef Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1984, 24: 29-43.CrossRef
6.
Zurück zum Zitat Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin W, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998, 90: 1371-1388. 10.1093/jnci/90.18.1371.CrossRefPubMed Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin W, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998, 90: 1371-1388. 10.1093/jnci/90.18.1371.CrossRefPubMed
7.
Zurück zum Zitat Bocchinfuso WP, Korack KS: Mammary gland development and tumorigenesis in estrogen receptor knock out mice. J Mammary Gland Biol Neoplasia. 1997, 2: 323-334. 10.1023/A:1026339111278.CrossRefPubMed Bocchinfuso WP, Korack KS: Mammary gland development and tumorigenesis in estrogen receptor knock out mice. J Mammary Gland Biol Neoplasia. 1997, 2: 323-334. 10.1023/A:1026339111278.CrossRefPubMed
8.
Zurück zum Zitat Humphreys R, Lydon J, O'Malley B, Rosen J: Use of the PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia. 1997, 2: 343-354. 10.1023/A:1026343212187.CrossRefPubMed Humphreys R, Lydon J, O'Malley B, Rosen J: Use of the PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia. 1997, 2: 343-354. 10.1023/A:1026343212187.CrossRefPubMed
9.
Zurück zum Zitat Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000, 92: 328-332. 10.1093/jnci/92.4.328.CrossRefPubMed Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000, 92: 328-332. 10.1093/jnci/92.4.328.CrossRefPubMed
10.
Zurück zum Zitat Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R: Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000, 283: 485-491. 10.1001/jama.283.4.485.CrossRefPubMed Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R: Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000, 283: 485-491. 10.1001/jama.283.4.485.CrossRefPubMed
11.
Zurück zum Zitat Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P: Functional domains of the human estrogen receptor. Cell. 1987, 51: 941-951.CrossRefPubMed Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P: Functional domains of the human estrogen receptor. Cell. 1987, 51: 941-951.CrossRefPubMed
12.
Zurück zum Zitat Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lager-crantz J, Fried G, Nordenskjold M, Gustafsson J-A: Human estrogen receptor β-gene structure, chromosomal location and expression pattern. J Clin Endocrinol Metab. 1997, 82: 4258-4265. 10.1210/jc.82.12.4258.PubMed Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lager-crantz J, Fried G, Nordenskjold M, Gustafsson J-A: Human estrogen receptor β-gene structure, chromosomal location and expression pattern. J Clin Endocrinol Metab. 1997, 82: 4258-4265. 10.1210/jc.82.12.4258.PubMed
13.
Zurück zum Zitat Hall J, McDonnell D: The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999, 140: 5566-5578. 10.1210/en.140.12.5566.PubMed Hall J, McDonnell D: The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999, 140: 5566-5578. 10.1210/en.140.12.5566.PubMed
14.
Zurück zum Zitat Clarke C, Sutherland RL: Progestin regulation of cellular proliferation. Endocr Rev. 1990, 11: 266-301.CrossRefPubMed Clarke C, Sutherland RL: Progestin regulation of cellular proliferation. Endocr Rev. 1990, 11: 266-301.CrossRefPubMed
15.
Zurück zum Zitat Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP: Human progesterone receptor A form is a cell and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol. 1993, 7: 1244-1255. 10.1210/me.7.10.1244.PubMed Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP: Human progesterone receptor A form is a cell and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol. 1993, 7: 1244-1255. 10.1210/me.7.10.1244.PubMed
16.
Zurück zum Zitat Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB: Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem. 2002, 277: 5209-5218. 10.1074/jbc.M110090200.CrossRefPubMed Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB: Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem. 2002, 277: 5209-5218. 10.1074/jbc.M110090200.CrossRefPubMed
17.
Zurück zum Zitat Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW: Reproductive functions of progesterone receptors. Recent Prog Horm Res. 2002, 57: 339-355. 10.1210/rp.57.1.339.CrossRefPubMed Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW: Reproductive functions of progesterone receptors. Recent Prog Horm Res. 2002, 57: 339-355. 10.1210/rp.57.1.339.CrossRefPubMed
18.
Zurück zum Zitat Clarke R, Howell A, Potten C, Anderson E: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 1997, 57: 4987-4991.PubMed Clarke R, Howell A, Potten C, Anderson E: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 1997, 57: 4987-4991.PubMed
19.
Zurück zum Zitat Skliris GP, Parkes AT, Limer JL, Burdall SE, Carder PJ, Speirs V: Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting and flow cytometry in human breast tissue. J Pathol. 2002, 197: 155-162. 10.1002/path.1077.CrossRefPubMed Skliris GP, Parkes AT, Limer JL, Burdall SE, Carder PJ, Speirs V: Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting and flow cytometry in human breast tissue. J Pathol. 2002, 197: 155-162. 10.1002/path.1077.CrossRefPubMed
20.
Zurück zum Zitat Speirs V, Skliris GP, Burdall SE, Carder PJ: Distinct expression patterns of ERα and ERβ in normal human mammary gland. J Clin Pathol. 2002, 55: 371-374.CrossRefPubMedPubMedCentral Speirs V, Skliris GP, Burdall SE, Carder PJ: Distinct expression patterns of ERα and ERβ in normal human mammary gland. J Clin Pathol. 2002, 55: 371-374.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Couse JF, Korach K: Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev. 1999, 20: 358-417. 10.1210/er.20.3.358.CrossRefPubMed Couse JF, Korach K: Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev. 1999, 20: 358-417. 10.1210/er.20.3.358.CrossRefPubMed
22.
Zurück zum Zitat Russo J, Ao X, Grill C, Russo IH: Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat. 1999, 53: 217-227. 10.1023/A:1006186719322.CrossRefPubMed Russo J, Ao X, Grill C, Russo IH: Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat. 1999, 53: 217-227. 10.1023/A:1006186719322.CrossRefPubMed
23.
Zurück zum Zitat Khan SA, Rogers MA, Obando JA, Tamsen A: Estrogen receptor expression of benign epithelium and its association with breast cancer. Cancer Res. 1994, 54: 993-997.PubMed Khan SA, Rogers MA, Obando JA, Tamsen A: Estrogen receptor expression of benign epithelium and its association with breast cancer. Cancer Res. 1994, 54: 993-997.PubMed
24.
Zurück zum Zitat Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D: Low oestrogen receptor α expression in normal human breast tissue underlies low breast cancer incidence in Japan. Lancet. 1999, 354: 1787-1788. 10.1016/S0140-6736(99)04936-3.CrossRefPubMed Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D: Low oestrogen receptor α expression in normal human breast tissue underlies low breast cancer incidence in Japan. Lancet. 1999, 354: 1787-1788. 10.1016/S0140-6736(99)04936-3.CrossRefPubMed
25.
Zurück zum Zitat Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP: Oestrogen receptor expression in the normal and precancerous breast. J Pathol. 1999, 188: 237-244. 10.1002/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.3.CO;2-#.CrossRefPubMed Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP: Oestrogen receptor expression in the normal and precancerous breast. J Pathol. 1999, 188: 237-244. 10.1002/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.3.CO;2-#.CrossRefPubMed
26.
Zurück zum Zitat Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MPA, Sibson DR, Sloane JP: Estrogen receptor positive proliferating cells in the normal and precancerous breast. Am J Pathol. 1999, 155: 1811-1815.CrossRefPubMedPubMedCentral Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MPA, Sibson DR, Sloane JP: Estrogen receptor positive proliferating cells in the normal and precancerous breast. Am J Pathol. 1999, 155: 1811-1815.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Roger P, Sahla M, Makela S, Gustafsson J-A, Baldet P, Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001, 61: 2537-2541.PubMed Roger P, Sahla M, Makela S, Gustafsson J-A, Baldet P, Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001, 61: 2537-2541.PubMed
28.
Zurück zum Zitat Speirs V: Oestrogen receptor β in breast cancer: good, bad or still too early to tell?. J Pathol. 2002, 197: 143-147. 10.1002/path.1072.CrossRefPubMed Speirs V: Oestrogen receptor β in breast cancer: good, bad or still too early to tell?. J Pathol. 2002, 197: 143-147. 10.1002/path.1072.CrossRefPubMed
29.
Zurück zum Zitat Mote PA, Bartow S, Tran N, Clarke CL: Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat. 2002, 72: 163-172. 10.1023/A:1014820500738.CrossRefPubMed Mote PA, Bartow S, Tran N, Clarke CL: Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat. 2002, 72: 163-172. 10.1023/A:1014820500738.CrossRefPubMed
Metadaten
Titel
Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
verfasst von
Elizabeth Anderson
Publikationsdatum
01.10.2002
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 5/2002
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr452

Weitere Artikel der Ausgabe 5/2002

Breast Cancer Research 5/2002 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.